Major Takeaways from National Neonatology Forum’s (NNF) Karnataka State Chapter, July 2020

Guidelines for Antenatal, Intranatal and Postnatal and New-born Management of COVID-19

The unprecedented scale of coronavirus infections or COVID-19 pandemic has affected the lives of millions of people across the globe. This has put tremendous strain on the health-care facilities and doctors, who are facing the direct brunt of this crisis and face numerous challenges in diagnosing and treating the affected people.

The central and state governments have been actively working with medical bodies such as ICMR and health-care facilities to formulate management guidelines for effectively tackling the growing number of COVID-19 infections.

Some of the most vulnerable population groups in this COVID-19 pandemic are pregnant mothers, mothers who have recently delivered a child and new-born babies. The National Neonatology Forum’s (NNF) Karnataka State Chapter has taken the initiative to draft and issue the “Guidelines for Antenatal, Intranatal and Postnatal and New-born Management of COVID-19”.

The NNF Karnataka State Chapter has prepared a comprehensive and evidence-based set of guidelines for the diagnosis and management of COVID-19 during pregnancy and delivery. It has been prepared by leading and eminent Neonatologists, Gynaecologists and Obstetricians from Karnataka.

This guideline prescribing standard operating procedures (SOPs) for the management of pregnant mothers and new-borns was released on 24th July 2020. The guideline has been duly endorsed by the Honourable Chief Minister of Karnataka, Shri BS Yediyurappa, Deputy Chief Minister, Dr. Ashwath Narayan CN, Honourable Health Minister of Karnataka, Shri B. Sreeramulu and Honourable Medical Education Minister, Dr. K. Sudhakar.

Brief Background of COVID-19

Towards the end of 2019, a coronavirus was identified to be the cause of a cluster of pneumonia cases in the city of Wuhan in China. The virus rapidly reached an epidemic scale across China and subsequently throughout the world. In February 2020, the World Health Organization (WHO) designated the disease caused by the coronavirus as COVID-19.

Recent studies have reported a variation in the viral genome of the coronavirus which has improved its ability to infect human cells. It has now become the dominant strain responsible for most COVID-19 cases. Common symptoms include fever, cough, sore throat, breathing issues, headache, and abdominal pain.

The coronavirus is primarily transmitted through close-range person-to-person contact mainly via respiratory droplets from an infected individual. Other modes of transmission are airborne, fomite, faecal-oral, blood born, and mother to child. Globally there are now close to 24 million confirmed COVID-19 cases and 3.2 million cases in India alone as of August 2020.

Management of COVID-19 and Pregnancy

Pregnant women undergo physiological and immunological changes. In the case of COVID-19 infection, most pregnant women experience mild or moderate symptoms. With the existing data, there is no evidence of an increased risk of miscarriage in COVID-19 positive mothers. The risk of vertical transmission or transmission from mother to foetus is also very low. Transmission of COVID-19 from breast milk to baby is extremely rare.

Source: NNF Karnataka State Chapter: Guidelines for Antenatal, Intranatal and Postnatal and New-born Management of COVID-19, July 2020

Highlights of Guidelines for Obstetric Health Care

  • All pregnant women will be treated as COVID-19 suspects and all precautionary measures will be followed.
  • The pregnant patient will be placed in a separate ward, negative pressure will be maintained in the Operation theatres (OT), the patients will wear a triple-layer mask.
  • All healthcare professionals must wear Personal Protection Equipment (PPE).
  • The Department of health and family welfare should be immediately notified for suspected COVID-19 cases and testing should be done at Government accredited labs.
  • The healthcare centres must maintain a registry of confirmed COVID-19 cases.
  • Healthcare centres will follow universal mask policy i.e. all visitors, patients, doctors, medical and non-medical staff will wear masks.
  • Sanitization of diagnostic equipment such as ultrasound machines will be done after each use.

Criteria for testing for COVID-19

Under certain circumstances, the pregnant patient will be needed to undergo testing for COVID-19. The following criteria will be used to prescribe the COVID-19 test:

  • Symptomatic persons will travel history in the past 14 days.
  • Patients with severe respiratory illness.
  • An asymptomatic person who has had direct contact with confirmed COVID-19 case.
  • In addition, ICMR has announced mandatory testing of patients living in COVID-19 hotspots or containment zones even if they are asymptomatic.

Management of pregnant patients with COVID 19

Most COVID-19 positive pregnant patients exhibit only mild symptoms. Severe symptoms are observed among immunosuppressed patients and patients with chronic conditions such as diabetes, lung disease, etc. Nevertheless, apart from the general precautions, particular considerations will be given to pregnant patients with COVID-19. Some of these include:

  • Maintaining high oxygen levels and keep saturations > 94%.
  • Conduct radiographic investigations such as chest X-ray using abdominal shielding.
  • Periodic blood analysis to monitor white blood cell count and prescribe antibiotics when necessary.
  • Current guidelines however do not recommend the use of Hydroxychloroquine or antiviral drugs in pregnant women.

Postnatal care for mothers with COVID-19

Limited information is available on the severity of COVID-19 symptoms exhibited in new-born babies born to mothers with COVID-19. However, the risk of transmission from mother to child after birth exists. Individualized care is recommended on a case-to-case basis after a thorough risk and benefit analysis with neonatologists and the concerned families.

Breastfeeding guidelines for mothers with COVID-19

It is extremely rare for transmission of COVID-19 from mother to baby through breast milk. It is strongly recommended to initiate breastfeeding within 1 hour of birth and that the baby is exclusively breastfed for the first 6 months.

Source: NNF Karnataka State Chapter: Guidelines for Antenatal, Intranatal and Postnatal and New-born Management of COVID-19, July 2020
  • Mothers confirmed with COVID-19 should breastfeed the baby with facemask and practice hand hygiene.
  • Face-mask should be worn during all events of contact with new-born.
  • If the baby and mother are required to be separated temporarily, expressed breast milk is strongly recommended to be given to the new-born by a healthy caregiver.
  • Gloves must be worn by the caregiver when receiving bottles of expressed breast milk. After securing the cap, the bottles should be wiped with viricidal wipes and air-dried on a clean surface.

In addition, the NNF Karnataka State Chapter also provides general guidelines for Basic Hospital Management, Visitor Policy, Managing Biomedical Waste, Mental Health and Wellness support for Patients and Healthcare Professionals and District Wise Government Helpline numbers in Karnataka.

Acknowledgements: We would like to acknowledge the Dr. Prashnath and Dr. Jyothi Bandi from LittleBaby Clinic for kindly permitting us to disseminate this information for the benefit of all.

Influence of air quality in IVF clinics on success rate of ART procedures

Our ever-changing  and rapidly evolving urban lifestyle is fueled by technology innovations in IT –  telecom, medicine and food. These innovations have significantly improved the quality of our life in terms of superior digital connectivity and access to information, easy access to quality healthcare services and food commodities. However, our modern lifestyle and occupational activities have also put us under increased exposure to various potentially harmful chemicals such as endocrine disrupting chemicals (EDC), volatile organic compounds (VOCs), heavy metals and pesticides. Studies have shown that long-term exposure to these chemicals, exhibit disruptions in male and female fertility, in both human and animals. [1, 2]

What are VOCs?

Where do they come from?

Why does it matter?

Concentrations of most volatile organic compounds are higher in indoor air than outdoor air

Health link BC

Consequently, exposure of gametes and embryos to such harmful chemicals can have detrimental effects on their growth and development. The environment requirements for gametes and embryos were initially adapted from tissue culture laboratory systems [3]. Better understanding and increased commercial interest for gametes and embryos has led to the recognition of the importance of laboratory air quality as an important factor for the safety of gamete and embryos in IVF clinics.

Several studies (primarily conducted between 1990 – 1998) have shown that poor laboratory conditions in fertility clinics, particularly the air quality can result in impairment of gametes and embryo development thereby reducing the success-rates of such fertility clinics. In fact, studies of air quality in the older ART/IVF laboratory/clinic designs (1990 – 1998) have indicated high concentrations of VOCs (like toluene and iso propyl alcohol) compared to outdoor environment, especially in the incubators. [3, 4]

Most of these IVF clinics/labs had high-efficiency particulate air (HEPA) filters which can remove particulate materials of size ~ 0.3 microns. However, HEPA filters offer limited protection from VOCs. VOC concentration greater than 1 ppm is considered high and can cause direct toxicity to embryos. Embryo development occurs reasonable well at VOC levels of ~ 0.5 ppm, however chances of miscarriage is also very high in such cases. The VOC levels should ideally be zero or at least less than 0.2 ppm. [5]

Carbon activated air filtration (CODA) systems were first implemented in 1997 and provided efficient filtration of VOCs. Clinics which installed CODA systems in addition to HEPA filters reported an increase in high quality embryos, reduction in miscarriages and higher clinical pregnancies. [5]

Regulatory bodies in the European Union and Brazil have specified the air quality requirements in ART laboratories in view of the damaging effects of VOCs and other air contaminants. [6]

Due to the growing amount of evidence suggesting that air contaminants can affect IVF outcome, cleanroom specifications for particulate and microorganism contamination in IVF laboratories have been enforced by European Union laws under Directive 2006/86/EC.

Esteves and Bento (2016), Asian Journal of Andrology

Heitmann et al (2015), reported a study wherein the mere improvement of air quality in their IVF facility by adopting CODA filters and strategic engineering designs of their lab, yielded nearly 10 % higher live births. No other changes were made to the laboratory equipment, protocols and lab personnel. [7]

Embryo implantation (32.4% versus 24.3%; P < 0.01) and live birth (39.3% versus 31.8%, P < 0.05) were significantly increased in the new facility compared with the old facility.

Heitmann et al. (2015), Reproductive Biomedicine Online

In another study, Khoudja et al. (2012) studied the influence of the use of a novel-air purification system on IVF outcomes. Their air purification system removes airborne molecular contaminants and chemical air contaminants in addition to VOCs. The results were compared to the outcomes prior to filter change. Few performance indicators are summarized below:

Improvements observed in IVF laboratory performance indicators after changes in air handling systems [5]

It can be clearly inferred from these studies that improvements in the air quality is fundamental for healthy embryo development and successful implantation rates, thereby coinciding with higher live births.

From this discussion, it is therefore imperative that fertility centers have better awareness about the importance of air quality and the factors which can contribute to air contamination inside clinics. The use of certain building materials such as vinyl, paints and fabrics can also contribute to increased VOC level in the clinic environment. New ventures in the IVF domain may unknowingly install vinyl flooring and other such materials for increased aesthetic appeal. This may inadvertently cause elevated levels of vinyl chloride (a known carcinogen) and other VOCs thereby posing a risk to all the stakeholders involved. Understanding and adherence to safety norms in IVF clinics will go a long way in ensuring high success rates of such clinics.


IVF – in-vitro fertilization

ART – Assisted Reproductive Technology

VOC – Volatile Organic Compound


[1] Rattan, S., Zhou, C., Chiang, C., Mahalingam, S., Brehm, E., & Flaws, J. A. (2017). Exposure to endocrine disruptors during adulthood: consequences for female fertility. Journal of Endocrinology, 233(3), R109-R129.

[2] Ten, J., Mendiola, J., Torres-Cantero, A. M., Moreno-Grau, J. M., Moreno-Grau, S., Roca, M., … & Bernabeu, R. (2008). Occupational and lifestyle exposures on male infertility: a mini review. The Open Reproductive Science Journal, 1(1), 16-21.

[3] Cohen, J., Gilligan, A., Esposito, W., Schimmel, T., & Dale, B. (1997). Ambient air and its potential effects on conception in vitro. Human reproduction (Oxford, England), 12(8), 1742-1749.

[4] Hall, J., Gilligan, A., Schimmel, T., Cecchi, M., & Cohen, J. (1998). The origin, effects and control of air pollution in laboratories used for human embryo culture. Human reproduction, 13(suppl_4), 146-155.

[5] Khoudja, R. Y., Xu, Y., Li, T., & Zhou, C. (2013). Better IVF outcomes following improvements in laboratory air quality. Journal of assisted reproduction and genetics, 30(1), 69-76.

[6] Esteves, S. C., & Bento, F. C. (2016). Air quality control in the ART laboratory is a major determinant of IVF success. Asian journal of andrology, 18(4), 596.

[7] Heitmann, R. J., Hill, M. J., James, A. N., Schimmel, T., Segars, J. H., Csokmay, J. M., … & Payson, M. D. (2015). Live births achieved via IVF are increased by improvements in air quality and laboratory environment. Reproductive biomedicine online, 31(3), 364-371.

ACE 2019, Chennai Blog

Our team was at ACE 2019 held in Chennai, at the Leela Palace on 20th-21st July 2019. There were two-parallel sessions held on both days. The event was well-attended by Doctors, Clinicians, Embryologists, Medical Technologists, Manufactures etc. The SpOvum® team had a stall for 2 days (from 20th – 21st July 2019). The products highlighted on our stall were the RoboICSI® Dashboard and the RoboScope time-lapse imaging system. Stall visitors were gifted our customized SpOvum® pens!

Our team at ACE 2019, Leela Palace, Chennai

Some of the noteworthy talks of ACE 2019 were

  • Unraveling the Secrets of Embryo Implantation” By Dr. Deepak Modi from NIRH, Mumbai
  • Doing ART legally” by Hitesh Bhatt
  • Is time lapse monitoring of embryos the future of embryo culture?” by Suresh Kattera
  • Can KPIs help programs identify shifts in quality?” by Dean Morbeck
  • Using artificial intelligence (AI) and time-lapse to improve human blastocyst morphology evolution” by Marcos Meseguer

There were also several interesting panel-discussions including one on “Real case scenarios in ART and management” and on “When good embryos fail…why and what next?”.

There was an engaging debate session on “Time-lapse imaging and incubation” wherein Dr. Keshav Malhotra spoke in favor of the technology and Dr. Pranay Ghose debated against it.

Interaction with Dr. Deepak Modi and Dr. Keshav Malhotra

Take home messages from ACE 2019

Views on Time-lapse imaging studies on embryos

Most clinicians/doctors were of the opinion that Time-lapse imaging of embryos, currently offered by commercially available devices, may not add much value to the existing ART procedures. One of the main hindrances, they believe, is the high cost involved in investing in a Time-lapse imaging system when it is possible for an embryologist to manually record/monitor the embryo development at various stages.

Most clinicians do not prefer being burdened with the additional amount of data obtained through Time-lapse imaging systems. Clinicians/doctors are also not particularly convinced about what additional value is delivered by Time-lapse imaging systems to an existing ART procedure especially when it is offered as an extra payable service to patients.

However, clinicians/doctors showed willingness to invest in Time-lapse embryo imaging systems, if:

  • It is offered at a lower cost
  • Some amount of automation and pre-processing of the image-data, which will enable the embryologists to look at only relevant/selected images

We believe this will be an advantage for us to effectively market the our own time lapse imaging system which aims at providing a cost-effective means to obtain time-lapse images of the developing embryo after IVF procedure. The TLM also has automated ability to monitor multiple embryos and there is promising scope to include image-processing and AI to the system.

Views on RoboICSI® Dashboard

There are many EHR and EMR handling systems. The RoboICSI® Dashboard features a distinct advantage wherein it offers ART related specialized data management to all the stake-holders involved in the ART procedure. The stake-holders include the Patients, the Doctors, the Clinicians, the Embryologists etc. They were particularly impressed that the Dashboard® does not require multiple entering of the same data and automated report generation.

Another important highlight was, more doctors presenting algorithms and more comfortable and pliant in handling large amounts of data.

Overall, our team had a great time at ACE 2019 and it was great opportunity to learn from other experts, connect with several doctors, clinicians, technologists and IVF service providers. We also got numerous constructive feedback on our products and many visitors also requested an early access to the RoboICSI® Dashboard.

Our team also had wonderful time trying out the local cuisine and also visited the famous Marina Beach in Chennai. After the event of ACE 2019, we bid farewell to one of our team members, Shubham who had worked with us since 2018. We wish him the best for his future endeavors.

RoboICSI ACE Goa 2018

RoboICSI was at ACE Goa 2018 from 17th-19th August at Holiday Inn resort. We had a 3 day stall were many embryologist, clinicians, distributors, freelancers, students, manufacturers, IVF product suppliers visited to know about the technology and the working of the product. We had a live demo setup for the visitors to get a feel of it.

                                          RoboICSI Soft Demo at the stall

There was a poster presentation by the team as well which was on ” Mechanics based characterization of oocytes using grippers” that explains about how bio-mechanical properties helps us to distinguish good and bad oocytes .

Poster presentation on ” Mechanics based characterisation of oocytes using grippers”

Dr Keshav Malhotra had presented a talk on “Automation in IVF” where he had talked about RoboICSI under Automation of ICSI on the 3rd day of the conference.

Clinics/ embryologists who were interested for a free demo of RoboICSI signed up with us at the stall to get to know more about the product.

There is a free signup for hands on training on RoboICSI at world-class Santaan-Origio Academy. To sign-up please do visit our blog post  Hands on Training on RoboICSI

RoboICSI Team at the stall in ACE Goa 2018

Santosh Bhargav giving a demo at the stall to the visitors

Dr Ramnath Babu & Dr Santosh Bhargav explaining how the product works

Happy to be at ACE Goa 2018

RoboICSI Team had a wonderful stay and experience at ACE Goa conference 2018. We got to meet many embryologists, Clinicians, Companies who were ready to connect and get to know about the product even further.

If there are any enquiry regarding the product, dashboard or any other information please visit our website  RoboICSI Website


RoboICSI is at ACE Goa 2018!!

Yet another opportunity for the people who have missed to meet RoboICSI and the team behind it.

Where? :  7th Annual congress, ACE Goa 2018 at Holiday Inn resort

When? :   Aug 17- 19th 2018

There are three segments at the conference where you can interact and know about the device and its interesting features.

  1. A 45 mins workshop on the device RoboICSI – Get to know about technology, benefits and many other interesting information.
  2. Stall– To have a hands on experience of the device, we are having a stall at the conference. You can walk into the stall to have a feel of the device and meet the team behind this device.
  3.  Poster presentation of RoboICSI on the topic – “Mechanics based characterization of oocytes using Grippers” 



RoboICSI Hands-on-training at Santaan-Origio Academy

Hands on training on RoboICSI at World- class Santaan- Origio Academy ,provides expert level experience in handling the device with ease. This training will be suitable for both Beginners and professional embryologists who are interested in learning about the new technology that RoboICSI works.

To register please fill out the form in the link below

Academy Registration


RoboICSI Team was at KISAR 2018 at Hotel Le Meridien, Bangalore on July 14th and 15th. There was a presentation and a two day stall at the venue for RoboICSI. A soft-demo setup of the device was kept at the stall were anyone could have a hands on experience of the device.

Many keen doctors, embryologists, clinicians, scientists visited the stall and used the device to get a feel of the product. Lot of questions, suggestions, feedback were given by the visitors.

There was also a quiz conducted by the team for the visitors. The quiz was very simple were they had to grade a given oocyte image. The idea behind the quiz was to make them understand that how easy it will be to grade the oocytes using the RoboICSI Dashboard. A special goody was given to all participants. It was a Petri dish holder, which also works in the same principle as RoboICSI – “compliant mechanism”.We had 20 enthusiastic visitors who took up the quiz.

RoboICSI team had a very attractive offer of providing the Dashboard free for first 6 months for all the visitors who had signed up with RoboICSI at KISAR. There was a total of 35 people who had signed up for the free Dashboard. The username passwords were sent to them the very next day.

These are few photos from the event:

Dr. Santosh Bhargav presenting about RoboICSI at KISAR 2018


RoboICSI Team at the stall


Dr. Ramnath Babu at the stall, explaining about the device



RoboICSI Soft-demo setup


RoboICSI goody for all quiz participants






At ESHRE 2018, RoboICSI team had a wonderful experience by presenting in front of the enthusiastic audiences. After the presentation there was a soft-demo session of the device ,were many keen audiences came forward to explore and have a Hands on experience of the product.

These are few images from ESHRE 2018 Barcelona, Spain



Dr. Santosh Bhargav, interacting with the audiences at the soft-demo session


            Dr. Ramnath Babu presenting about RoboICSI at ESHRE 2018